Evidence map›Paper›PMID 32286350›Full record

ArticleNature communications2020

Synthetic biology based construction of biological activity-related library of fungal decalin-containing diterpenoid pyrones.

Kento Tsukada, Shono Shinki, Akiho Kaneko, Kazuma Murakami, Kazuhiro Irie, Masatoshi Murai, Hideto Miyoshi, Shingo Dan, Kumi Kawaji, Hironori Hayashi and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Identification and Confirmation of Virulence Factor Production fromJournal of fungi (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Kento TsukadaDepartment of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku, Tokyo, 153-8902, Japan.
Shono ShinkiDepartment of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku, Tokyo, 153-8902, Japan.
Akiho KanekoDepartment of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku, Tokyo, 153-8902, Japan.
Kazuma MurakamiDivision of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.ORCID http://orcid.org/0000-0003-3152-1784
Kazuhiro IrieDivision of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.ORCID http://orcid.org/0000-0001-7109-8568
Masatoshi MuraiDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.ORCID http://orcid.org/0000-0001-6601-2854
Hideto MiyoshiDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.ORCID http://orcid.org/0000-0002-1792-554X
Shingo DanDivision of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Kumi KawajiDepartment of Infectious Diseases, International Research Institute of Disaster Science, Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryocho, Aoba-ku, Sendai, 980-0875, Japan.
Hironori HayashiDepartment of Intelligent Network for Infection Control, Graduate School of Medicine, Tohoku University, 2-1, Seiryocho, Aoba-ku, Sendai, 980-0875, Japan.
Eiichi N KodamaDepartment of Infectious Diseases, International Research Institute of Disaster Science, Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryocho, Aoba-ku, Sendai, 980-0875, Japan.
Aki HoriFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
Emil SalimFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
Takayuki KuraishiFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
Naoya HirataDivision of Pharmacology, National Institute of Health Sciences, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.ORCID http://orcid.org/0000-0002-2312-9443
Yasunari KandaDivision of Pharmacology, National Institute of Health Sciences, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.
Teigo AsaiDepartment of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku, Tokyo, 153-8902, Japan. teigo.asai.c8@tohoku.ac.jp.ORCID http://orcid.org/0000-0002-8903-392X
Kyoto University · JPTohoku University · JPKanazawa University · JPThe University of Tokyo · JPNational Institute of Health Sciences · JPJapanese Foundation For Cancer Research · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A synthetic biology method based on heterologous biosynthesis coupled with genome mining is a promising approach for increasing the opportunities to rationally access natural product with novel structures and biological activities through total biosynthesis and combinatorial biosynthesis. Here, we demonstrate the advantage of the synthetic biology method to explore biological activity-related chemical space through the comprehensive heterologous biosynthesis of fungal decalin-containing diterpenoid pyrones (DDPs). Genome mining reveals putative DDP biosynthetic gene clusters distributed in five fungal genera. In addition, we design extended DDP pathways by combinatorial biosynthesis. In total, ten DDP pathways, including five native pathways, four extended pathways and one shunt pathway, are heterologously reconstituted in a genetically tractable heterologous host, Aspergillus oryzae, resulting in the production of 22 DDPs, including 15 new analogues. We also demonstrate the advantage of expanding the diversity of DDPs to probe various bioactive molecules through a wide range of biological evaluations.

Indexed as

Synthetic BiologyAmyloid beta-PeptidesAnimalsAnti-HIV AgentsAspergillusBiosynthetic PathwaysCell ProliferationDiterpenesDrosophilaFungiGenome, FungalHIV-1HumansMCF-7 CellsNaphthalenesNeoplastic Stem CellsAmyloid beta-PeptidesAnti-HIV AgentsdecalinDiterpenesNaphthalenesProtein AggregatesPyrones

Identifiers

PMID32286350
PMCPMC7156458
OpenAlexW3015682385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.